Jiuzhou Pharmaceutical: Completed repurchase of 15.4128 million shares, paid 212 million yuan.

Jiuzhou Pharmaceutical announced that the company had previously planned to repurchase shares for an amount between RMB 200 million and RMB 400 million, with a maximum repurchase price of RMB 19.9 per share, for the purposes of reducing registered capital and implementing an employee stock ownership plan or equity incentive. The company has completed the repurchase, actually repurchasing 15.4128 million shares, accounting for 1.75% of the total share capital, at transaction prices ranging from RMB 12.12 per share to RMB 16.07 per share, with a total payment of RMB 212 million; of these, 6.1651 million shares will be cancelled on September 30, 2026, and the remaining 9.2477 million shares are intended to be used for an employee stock ownership plan or equity incentive.